AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Ion Beam Applications, SA

Major Shareholding Notification Nov 10, 2016

3960_mrq_2016-11-10_35d8dbf8-33b1-4d57-8858-ed9c48bb5950.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

IBA – DATA CONCERNING TRANSPARENCY

Louvain-la-Neuve, Belgium, November 10, 2016, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has received on November 8, 2016 a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007, the content of which is summarized below (see on next page).

Press release | September 22, 2016 1 | 6

FSMA HUTSHIRES HOOK HIGH-DOUGH
WEIGHT NOW THANK
Formulier TR-1 BE
PARTI
Transparantiekennisgeving
1. Status van de kennisgeving
Definited
2. Emittent
Naam
identification states
IBA
0429-750-885
3. Reden your de kennisgeving
Verwerving of querbracht van stemmuthivertenande effecten af stemmachten
4. Kennisgeving door
Ean persoon dia alleen kernis geeft
5. Kennisgevingsplichtige personen
NAMY Adres (your juridische antiturian)
Capfi Delen Asset Management nv Jan Van Rijswijcklaan 178 - 2020 Antwerpen
6. Overdrager(s) yan stemmechten review into uzter inter arthal 7 van its wet ver 3 mei 397 van toeptoorg ac
Nistra Altres (voor juridactie entituitee)
o Seleve in "PART 3" de gegevens van de personant bedoeld to
induriation if you 6 yearshir again to realise).
PART II
7. Datum van drempelovemchriding
02/11/2016 (DD/HM/YYYY)
5. Overschreden drempel in %
э
indian de destreming la petitalit under de longate drampel,
67 Januari in mellios ed in energegnerate meeg me give a ted fascis
9. Noemer
29.585.703
Gettone do reserver in ta gasan alwarens de cifforgageverse in te vollen
10. Details van de kennisgeving Ma de transactio
Vorige benningsving
A) Stererechten Kaliformation % storeroctrien
History VIII Marineshiero Kalemathlan Verbunden asir
offecter)
Los yan or effects Verbunden san
efecter
Los van de effecte
Capft Delan Asset Management no 888.372 3.21%
TOTAAL 889,372 × 3,01% 5,07%
Φ Beginson met "groepen" van friszlera, auditotalen tivestutgen met 22,
en earystyms sindtym met personali die "shaer" zijn.
Vice "gringwo", lingtimest cost the attempt controllerandly nationalities persons of justification willted.

Press release | September 22, 2016 2 | 6

IBA sa. | Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | Tel.: + 32 10 47 58 11 | Fax: + 32 10 47 58 10 | E-mail: [email protected] | www.iba-worldwide.com | RPM Nivelles | VAT: BE 0428.750.985

Press release | September 22, 2016 3 | 6

Press release |

Regulated information

No de transactio it atassurection
Hasdare yes:
geljigesteide
Thancille instrumentes
Type financies/ instrument Vervestessen
DDAMATYYY
Ukontenegemente
of distant
DOMANYYY chase
die kussen.
sepriteri
renworver bij de
situateing van
Test Statisticians
% stemmeltism Attwibousting
TOTAAL $\alpha$ LIPS
œ De Malaren zuhen pas geschadtenent werden no da knop «BERENSTSEM» to hebben gebruikt.
TOTAAL (A & B) # stammechten % attempecture.
REALKENEN 889.571 3,01%
za bijage bij de kernageving
12. Wanneer stemrechten worden gehouden ingevolge volmacht voor een enkele AV.
SRAMMYTON
Houder zal niet langer / zał
GOTTRIAN
a INNOVERSIDE (Novins view)
13. Bilkomende informatie
visiteting conform art 11 van de transporantment
Gedaan te Arhwerpen
07/15/2016 (DDAMAYYYY)
Naam & hoodanigheid Chris Bruyneeels, gecelegoerd bestuurder Handlekening

Press release | September 22, 2016 4 | 6

Press release |

Regulated information

Press release | September 22, 2016 5 | 6

* * * *

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,400 people worldwide, IBA has installed systems across the world.

IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: www.iba-worldwide.com .

For more information, please contact

IBA Caroline Hardy Corporate Legal Counsel +32 10 201 159 [email protected]

Press release | September 22, 2016 6 | 6

Talk to a Data Expert

Have a question? We'll get back to you promptly.